Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...
Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable ...
FDA approves doravirine/islatravir, a once-daily, 2-drug, single-tablet HIV regimen showing noninferior efficacy to standard ...
The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically ...
Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by ...
For those seeking the same medication at a lower cost, check for the PL code printed on the packaging. This is the licence ...
Around eight million Brits take statins for cholesterol, but experts warn this juice can make the medication more powerful ...
Around eight million people in the UK take statins for cholesterol, but NHS warns this juice can affect some statins ...
Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...
These data were simultaneously published in The Lancet: “ Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results